CRL


Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.

CRL

Carnegie Representation Language.

Carnegie Group, Inc. Frame language derived from SRL. Written in Common LISP. Used in the product Knowledge Craft.
References in periodicals archive ?
The CRL also included a request to conduct another human factors study to demonstrate that the product packaging and instructions for use are effective, and the CRL requested, among other things, additional product quality information with respect to microbiology and a new in vitro drug release method development report.
He said: "I was looking to take the business on to the next level in an innovative way and when I heard about the CRL technology, it sounded a perfect match for us.
CRL performs a wide range of clinical safety and efficacy testing which can be categorized into three primary areas including: (i) Repeated Insult Patch Test ("RIPT") which is the industry standard for dermal sensitization testing; RIPT is used predominately for skin care products, color cosmetics, woven and non-woven fabrics and fragrances, (ii) In-Use Safety Studies which allow product vendors to make dermatological safety in-use claims such as "Dermatologist Tested" and "Safe for Sensitive Skin" or any other substantive safety claims, and (iii) traditional efficacy and safety assessments that provide results of the efficacy of a particular consumer product and product claim substantiation and authentication.
Maximum number of female fetus were seen with 14cms, 23cms, 25cms and 32cms CRL (4 each).
Francesco D'Antonio, a researcher for the study, said evidence was building that CRL discordance at the 11- to 14-week mark was not a useful indicator of pregnancy outcomes.
Multiple CRL units can be positioned along a cartoner's infeed conveyor to enable product from additional sources to be combined, enabling the full speed capacity of the cartoner to be utilised.
While we have seen that the investor groups have taken issue with the Inveresk purchase price, CRL also apparently miscalculated its assertion that the Inveresk operations would be integrated with their existing preclinical operations within a year.
CRL said that the scheme, due for completion in 2017 was worth Au42 billion to the UK economy, a figure in excess of a previous estimate of Au36 billion.
These assets may be subject to impairment after the company reviews the new CRL but the potential impairment will not be included in the company's core earnings.
The company also received a CRL for Nexium for reducing the risk of low-dose aspirin-associated peptic ulcers.
Out of the 100 respondents interviewed, 11% are from ADRC, 22% from AICB, 9% from BRA, 24% from CRL, 6% from DC, 17% from DPL and 16% from RNBTBL.